Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

New bladder-selective M3 antagonist reported by Yamanouchi

April 16, 1997

Potential BPH therapy from Abbott

April 16, 1997

Placebo associated with improvement and side effects in treatment of BPH

April 16, 1997

GG-745 compared to finasteride in BPH patients

April 15, 1997

Furosemide vs. placebo for nocturnal polyuria

April 15, 1997

Initial clinical results with vinpocetine for urge incontinence

April 15, 1997

Mechanism of impaired erection with finasteride elucidated

April 15, 1997

Development of Auriculin suspended

April 14, 1997

Fujsawa selects adenosine A1 receptor antagonist for development

April 11, 1997

Synthelabo reports agents for urinary incontinence

April 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...
AI drug developer Insilico to raise $292 million in Hong Kong IPO
BioWorld
Insilico Medicine Inc. plans to raise HK$2.27 billion (US$292 million) in its IPO on the Hong Kong Securities Exchange to advance its clinical pipeline and invest...